MedPath

A comparative study on the pain control effect and safety of a local area pain control device (On-Q® or PainBuster®) compared to a conventional intravenous injection patient control analgesic device (PCA) in a pregnant woman undergoing cesarean section.

Not Applicable
Completed
Conditions
Pregnancy, childbirth and the puerperium
Registration Number
KCT0005108
Lead Sponsor
The Catholic University of Korea, Uijeongbu St. Mary’s Hospital
Brief Summary

Sixty-nine patients (35 in the study and 34 in the control group) were analyzed. The mean VAS scores were lower in the study group all three periods, with significance achieved at day 2 (2.74 ± 0.0.95 versus 3.41 ± 1.33, p=0.0287). The intravenous fentanyl consumptions were significantly lower in the study group at all three periods. Total administration of additional non-opioid analgesics including ketorolac, propacetamol, and pethidine was higher in the control group.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
69
Inclusion Criteria

1) women planning to get the cesarean section delivery
2) women who can read and understand the Korean.
3) women without the exclusion criteria
4) women giving informed consent

Exclusion Criteria

Exclusion criteria :
1) A person who has allergic reaction to the bupivacaine
2) Drug addicts or alcoholics
3) A person with a history of mental illness
4) Serum Creatinine > 2mg/d

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
pain scaling score
Secondary Outcome Measures
NameTimeMethod
fentanyl concentration
© Copyright 2025. All Rights Reserved by MedPath